RBP2 induces epithelial-mesenchymal transition in non-small cell lung cancer.
RBP2 has been found to actively participate in cancer progression. It inhibits the senescence of cancer cells, mediates cancer cell proliferation and promotes cancer metastasis. It is also essential to drug tolerance. However, the effects of RBP2 on epithelial-mesenchymal transition are still unknow...
Main Authors: | Shikun Wang, Yang Wang, Haijian Wu, Likuan Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3869927?pdf=render |
Similar Items
-
Association between the telomerase reverse transcriptase (TERT) rs2736098 polymorphism and cancer risk: evidence from a case-control study of non-small-cell lung cancer and a meta-analysis.
by: Haijian Wu, et al.
Published: (2013-01-01) -
An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer
by: Richard J. Lobb, et al.
Published: (2023-01-01) -
Icotinib inhibits proliferation and epithelial-mesenchymal transition of non-small cell lung cancer A549 cells
by: Guohai Wang, et al.
Published: (2019-08-01) -
CTEN induces epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung cancer cells.
by: Xiangdong Lu, et al.
Published: (2018-01-01) -
Gli promotes tumor progression through regulating epithelial-mesenchymal transition in non–small-cell lung cancer
by: Long Jiang, et al.
Published: (2020-01-01)